Saturday, April 8, 2017

Raffles Medical Group Ltd. (R01):

Latest update as of 05/04/2017 @$1.45:
  • Raffles Medical Group has recently announced its plan to develop a 700-bed hospitals in Chongqing with target completion by 2Q18. 
  • I personally believe on Raffles Hospital extension and China hospital projects could positively generate profits in the long run. 
  • Furthermore, Singapore and China have been collaborating closely in the planning and implementation of the Chongqing Connectivity (CCI). With such joint implementation and strategic location of Chongqing with connectivity to central Asia, Russia and Europe (Chongqing-Xinjiang-Europe), this could potentially grows the number of populations in its province. 
  • For more details information, please refer to sources from:
    - research.sginvestors.io > Raffles Medical Group: New hospital in Chongqing strategically located.

Latest update as of 03/04/2017 @$1.43:
  • Raffles Medical Group inks agreement with Chongqing government for second hospital in China.
  • Raffles Medical Group announced that it has acquired a piece of land with estimated land area of 28,000 sqm together with an in-construction building thereon, located in the New North District of the Liangjiang New Area in Chongqing for the development of a 700- bed international tertiary general hospital. 
  • The construction is targeted to be completed in 2Q18 and the hospital will provide high quality and comprehensive healthcare services to local, expatriate and international patients.
  • For more details information, please refer to sources from:
    research.sginvestors.io > Raffles Medical - Riding On One Belt, One Road.
    sgx.i3investor.com > Raffles Medical Group: Buys land in China to develop hospital.


Latest update as of 21/02/2017 @$1.45:
  • Raffles Medical Group 4Q16 revenue grew 15.4%. Revenue was driven by a 30.8% improvement in Healthcare services and a 6.3% increase for Hospital services. 
  • Due to stronger SGD against currencies like IDR, MYR, coupled with strong regional competition, overall foreign patient volume growth is expected to be small.
  • The Raffles Hospital Extension is also expected to be completed by 4Q17, with about half the space for own expansion plans while the other half will be leased out. 
  • For more details information, please refer to sources from:
    research.sginvestors.io > Raffles Medical Group: Growth in progress.


Latest update as of 15/01/2016 @$3.95:
  • Raffles Medical Group has always been a reputable organisation with its strong brand name. The organisation also offers a wide range of products and services through its well established network.
  • Recommended as a long term stocks to look into, with its track record of growing dividend, strong operating cash flow and intact growth story. 
  • For more details information, please refer to sources from:
    internetfileserver.phillip.com.sg > Raffles Medical Group Ltd (RMG).




No comments:

Post a Comment